-

01:40:50 AM

CDNA Stock News

CDNA - Caredx Inc

10/21/21 7:00 AM

Nasdaq : CDNA

CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study

CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and

RHEA-AI

neutral

10/19/21 7:00 AM

Nasdaq : CDNA

CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company

RHEA-AI

neutral

10/14/21 4:01 PM

Nasdaq : CDNA

conferencesearnings

CareDx to Report Third Quarter 2021 Financial Results

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today

RHEA-AI

neutral

10/12/21 10:18 AM

Nasdaq : CDNA

AlloSure, the First dd-cfDNA in Heart and Kidney Transplantation, Launches for Lung Transplant Patients

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically

RHEA-AI

neutral

09/30/21 4:01 PM

Nasdaq : CDNA

CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication

CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and

RHEA-AI

neutral

09/28/21 7:18 PM

Nasdaq : CDNA

CareDx Continues to Fight for Innovation in Transplantation

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and

RHEA-AI

neutral

09/27/21 7:00 AM

Nasdaq : CDNA

CareDx Presents Latest Data on AlloSeq Portfolio at ASHI 2021

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,

RHEA-AI

neutral

09/15/21 8:00 AM

Nasdaq : CDNA

management

CareDx Names Longtime Patient Advocate Art Torres to Board of Directors

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically

RHEA-AI

neutral

09/02/21 7:00 AM

Nasdaq : CDNA

conferences

CareDx to Participate in Upcoming Conferences

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,

RHEA-AI

neutral

08/26/21 7:00 AM

Nasdaq : CDNA

CareDx Showcases Leadership in Global Transplantation at ESOT 2021

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,

RHEA-AI

neutral

Prev 1 2 3 4 5 6 7 8 9 10 Next

CDNA Data

IndustryMedical Laboratories
Websitewww.caredx.com
CeoPeter Maag
Security nameCaredx Inc
Issue typecs
SectorHealth Care and Social Assistance
Sic code8071
Employees466
Tags
- Health Technology
- Medical Specialties
- Health Care and Social Assistance
- Medical Laboratories
Address1 Tower Place
Address29Th Floor
StateCalifornia
CitySouth San Francisco
Zip94080
CountryUS
Phone14152872300

About Caredx Inc

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.